Inmode (INMD) Stock Price
Inmode Price
Inmode (INMD) Stock | ISIN IL0011595993 | WKN A2PP3A. The current Inmode stock price is 13.49 USD (2026). Revenue is 376.78 M USD. Net income is 93.45 M USD. The P/E ratio is 9.45. Market capitalization is 854.73 M USD. Inmode operates in the Health sector.
Over the last 9 years Inmode grew revenue by 36.1% annually, reaching 370.5 M USD. Earnings per share have grown at 88.8% per year over the last 9 years. For Inmode, the net margin of 25.3% is down versus 46.1% a few years ago.
Inmode stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Inmode over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Inmode stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Inmode's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Inmode Price |
|---|
Inmode Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Inmode Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (M USD) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (M USD) |
| NET INCOME (M USD) |
| NET INCOME GROWTH (%) |
| SHARES (M) |
| DOCUMENTS |
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|
| 357 | 454 | 492 | 394 | 370 | 376 | 391 | 398 |
| 73.3 | 27.17 | 8.37 | -19.92 | -6.09 | 1.62 | 3.99 | 1.79 |
| 85.15 | 83.7 | 83.54 | 80.46 | 78.38 | 77.13 | 74.17 | 72.86 |
| 304 | 380 | 411 | 317 | 290 | 290 | 290 | 290 |
| 165 | 161 | 197 | 181 | 93 | 93 | 99 | 107 |
| 120 | -2.42 | 22.36 | -8.12 | -48.62 | – | 6.45 | 8.08 |
| 86 | 85.4 | 85.95 | 80.6 | 65.44 | 65.44 | 65.44 | 65.44 |
| – | – | – | – | – | – | – | – |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Inmode generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Inmode retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Inmode's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Inmode has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Inmode's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Inmode stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Inmode Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Inmode business model & stock analysis
Inmode SWOT Analysis
Strengths
1. Innovation-driven: Inmode Ltd is known for its continuous innovation in the medical aesthetics industry, offering advanced technologies and treatment options.
2. Strong product portfolio: The company has a diverse range of high-quality products and solutions, including minimally invasive and non-invasive treatments, which cater to various customer needs.
3. Established brand: Inmode Ltd has built a solid reputation and brand presence in the market, gaining trust and recognition from both healthcare professionals and patients.
Weaknesses
1. Dependence on key markets: Inmode Ltd heavily relies on specific geographic regions, which may expose the company to market-specific risks and fluctuations.
2. Limited global reach: While the company has expanded its presence internationally, it still has room for further expansion to tap into untapped markets and increase market share.
3. Intense competition: Inmode Ltd faces fierce competition from other established players and emerging companies in the medical aesthetics sector. Maintaining and expanding market share can be challenging.
Opportunities
1. Growing demand for non-invasive treatments: The increasing preference for non-surgical aesthetic procedures presents an opportunity for Inmode Ltd to further expand its product offerings and capture a larger market share.
2. Rising consumer awareness: As consumer awareness about the benefits of aesthetic treatments increases, there is a potential for Inmode Ltd to educate and attract more customers, driving demand for its products.
3. Technological advancements: By staying at the forefront of technological advancements, Inmode Ltd can continue to develop and introduce innovative solutions, strengthening its competitive position in the market.
Threats
1. Regulatory challenges: Government regulations and guidelines related to medical devices and aesthetic treatments can pose challenges and impact the market potential of Inmode Ltd.
2. Economic downturns: In times of economic uncertainty or recessions, consumers may reduce their discretionary spending on aesthetic treatments, leading to a potential decline in demand for Inmode Ltd's products.
3. Counterfeit products and unauthorized distributors: The presence of counterfeit products and unauthorized distributors can harm Inmode Ltd's brand reputation and result in revenue losses.
Inmode Segments
Inmode Revenue by Segment
Max
Details
Inmode Revenue by Region
3 Years
Max
Details
Inmode Eulerpool Fair Value
Inmode historical P/E ratio, EBIT multiple, and P/S ratio
Inmode annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Inmode shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Inmode Earnings Estimates
Inmode Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 5/6/2026 | 0.3USD | 81.8 MUSD | 2026 Q1 |
| 5/4/2026 | 0.3USD | 81.45 MUSD | 2026 Q1 |
| 4/27/2026 | 0.3USD | 81.45 MUSD | 2026 Q1 |
| 2/10/2026 | 0.43USD | 106.49 MUSD | 2025 Q4 |
| 4/30/2024 | 0.54USD | 113.92 MUSD | 2024 Q1 |
| 2/12/2024 | 0.7USD | 141.71 MUSD | 2023 Q4 |
| 7/26/2023 | 0.68USD | 136.72 MUSD | 2023 Q2 |
| 5/1/2023 | 0.46USD | 104.59 MUSD | 2023 Q1 |
| 2/8/2023 | 0.67USD | 131.62 MUSD | 2022 Q4 |
| 10/27/2022 | 0.6USD | 115.09 MUSD | 2022 Q3 |
Inmode shareholder structure
| % | Name |
|---|---|
5.52277% | |
4.91598% | |
4.47985% | |
4.09799% | |
3.84536% | |
2.80726% | |
2.67783% | |
2.24532% | |
1.70836% | |
1.45226% |
Inmode Executives and Management Board
Mr. Michael Dennison
(45)President, North America
Mr. Yair Malca
(48)Chief Financial Officer
Dr. Michael Kreindel
(59)Chief Technology Officer, Director · since 2008
Dr. Michael Anghel
(87)Independent Chairman of the Board
Mr. Moshe Mizrahy
(73)Chief Executive Officer · since 2008
Inmode Supply Chain
Frequently asked questions about Inmode
The business model of Inmode Ltd revolves around providing innovative medical aesthetics solutions. Inmode Ltd develops and markets advanced, minimally-invasive technologies used in aesthetic and surgical procedures. Their cutting-edge platforms, such as BodyTite, FaceTite, and Morpheus8, offer solutions for skin tightening, body contouring, facial rejuvenation, and cellulite reduction. Inmode Ltd's business model centers on combining radiofrequency technology with other modalities to deliver safe, efficient, and customizable treatments for both medical professionals and patients. By continuously developing and enhancing their product portfolio, they aim to meet the growing demands of the global aesthetic market and cater to the evolving needs of healthcare practitioners.
Inmode stock
Inmode Ticker
Inmode FIGI
All fundamentals and in-depth analysis of Inmode
Our stock analysis for Inmode Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Inmode Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.